Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Trial of Response-Based Radiation Therapy for Patients With Localized Central Nervous System Germ Cell Tumors (CNS GCT)

NCT01602666 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT01602666
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01602666 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Trial of Response-Based Radiation Therapy for Patients With Localized Central Nervous System Germ Cell Tumors (CNS GCT)
Lead sponsor
Children's Oncology Group
Phase
Phase 2
Overall status
Completed
Start date
June 27, 2012
Completion date
September 30, 2024
Enrollment
262 (actual)
Sites
167

Conditions

As the registry lists them; a condition with its own page is linked.

central nervous system nongerminomatous germ cell tumor, childhood germinoma